| Dorzolamide |
II-1823/31.03.2008 |
Trusopt, -, 2% - 5ml, mg, Pack: 1 |
Мерк Шарп и Доум България ЕООД, България |
Laboratoires Merck Sharp & Dohme – Chibret (Mirabel Plant), Route de Marsat, F-63963, Clermont –Ferranf cedex 9, France |
10.68 |
2.14 |
12.82 |
6% |
0.64 |
11.32 |
2.26 |
13.58 |
18% |
1.92 |
13.24 |
2.65 |
15.89 |
|
КЦ-3144/04.11.2011 |
12.02.2012 |
12.02.2012 |
Неактивен |
2548 |
| Dorzolamide |
II-1823/31.03.2008 |
Trusopt, -, 2% - 5ml, mg, Pack: 1 |
Мерк Шарп и Доум България ЕООД, България |
Merck Sharp & Dohme B.V.- The Netherlands; Laboratoire Merck Sharp & Dohme - Chilbert, Mirabel Plant-France |
15.26 |
3.05 |
18.31 |
8% |
1.22 |
16.48 |
3.3 |
19.78 |
20% |
3.05 |
19.53 |
3.91 |
23.44 |
цената е променена |
КЦ-708/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
2548 |
| Emtricitabine, Tenofovir disoproxil |
EU/1/04/305/001 |
Truvada, Film coated tablet, 200 mg/245 mg, UD, Pack: 30 |
Gilead Sciences International Ltd., Обединено Кралство |
Gilead Sciences Limited,, Ирландия |
815.7 |
163.14 |
978.84 |
4% |
10 |
825.7 |
165.14 |
990.84 |
16% |
25 |
850.7 |
170.14 |
1020.84 |
|
НСР-7001/24.08.2015. |
08.09.2015 |
08.09.2015 |
Активен |
3360 |
| Emtricitabine, Tenofovir disoproxil |
EU/1/04/305/001 |
Truvada, Film coated tablet, 200 mg/245 mg, UD, Pack: 30 |
Gilead Sciences International Ltd., Обединено Кралство |
Gilead Sciences Limited,, Ирландия |
823.89 |
164.78 |
988.67 |
4% |
10 |
833.89 |
166.78 |
1000.67 |
16% |
25 |
858.89 |
171.78 |
1030.67 |
|
НСР-5064/21.11.2014 |
08.12.2014 |
08.12.2014 |
Неактивен |
3360 |
| Solifenacin |
20120213 |
Truzor, Film coated tablet, 5, mg, Pack: 30 |
Sandoz d.d., Словения |
Sanitas AB, Литва; Lek Pharmaceuticals d.d., Словения |
27.11 |
5.42 |
32.53 |
6% |
1.63 |
28.74 |
5.75 |
34.49 |
18% |
4.88 |
33.62 |
6.72 |
40.34 |
|
НСР-5165/27.11.2014 |
11.12.2014 |
11.12.2014 |
Активен |
3405 |
| Solifenacin |
20120213 |
Truzor, Film coated tablet, 5, mg, Pack: 30 |
Sandoz d.d., Словения |
Sanitas AB, Литва; Lek Pharmaceuticals d.d., Словения |
31.29 |
6.26 |
37.55 |
4% |
1.25 |
32.54 |
6.51 |
39.05 |
16% |
5.01 |
37.55 |
7.51 |
45.06 |
|
НСР-1297/03.10.2013 |
18.10.2013 |
18.10.2013 |
Неактивен |
3405 |
| Rifampicin |
9900243 |
TUBOCIN, Capsule, hard, 300, mg, Pack: 100 |
Актавис EАД, България |
Балканфарма Разград, България |
26.66 |
5.33 |
31.99 |
6% |
1.6 |
28.26 |
5.65 |
33.91 |
18% |
4.8 |
33.06 |
6.61 |
39.67 |
|
HCР-410/03.07.2013. |
18.07.2013 |
18.07.2013 |
Активен |
1956 |
| Rifampicin |
II-10182/28.12.2004 |
TUBOCIN, Capsule, hard, 300, mg, Pack: 100 |
Актавис EАД, България |
Балканфарма Разград, България |
24 |
4.8 |
28.8 |
6% |
1.44 |
25.44 |
5.09 |
30.53 |
18% |
4.32 |
29.76 |
5.95 |
35.71 |
|
КЦ-507/06.02.2009 |
19.02.2009 |
19.02.2009 |
Неактивен |
1956 |
| Atorvastatin |
ІІ-14747/08.11.2006 г. |
TULIP, Film coated tablet, 10, mg, Pack: 30 |
Lek Pharmaceuticals d.d., Словения |
Lek Pharmaceutical d.d., Slovenia |
2.23 |
0.45 |
2.68 |
7% |
0.16 |
2.39 |
0.48 |
2.87 |
20% |
0.45 |
2.84 |
0.57 |
3.41 |
Отхвърлена като неоснователна жалбата от Комисия по прозрачност КП-296/02.06.2015 |
НСР-3962/30.06.2014 |
16.06.2015 |
16.06.2015 |
Активен |
3447 |
| Atorvastatin |
ІІ-14748/08.11.2006 г. |
TULIP, Film coated tablet, 20, mg, Pack: 30 |
Lek Pharmaceuticals d.d., Словения |
Lek Pharmaceutical d.d., Slovenia |
4.32 |
0.86 |
5.18 |
7% |
0.3 |
4.62 |
0.92 |
5.54 |
20% |
0.86 |
5.48 |
1.1 |
6.58 |
|
НСР-5320/ 18.12.2014. |
01.01.2015 |
01.01.2015 |
Активен |
3448 |
| Atorvastatin |
ІІ-14747/08.11.2006 г. |
TULIP, Film coated tablet, 10, mg, Pack: 30 |
Lek Pharmaceuticals d.d., Словения |
Lek Pharmaceuti-cal d.d., Slovenia |
2.58 |
0.52 |
3.1 |
7% |
0.18 |
2.76 |
0.55 |
3.31 |
20% |
0.52 |
3.28 |
0.66 |
3.94 |
|
НСР-5319/ 18.12.2014. |
01.01.2015 |
01.01.2015 |
Неактивен |
3447 |
| Atorvastatin |
ІІ-14747/08.11.2006 г. |
TULIP, Film coated tablet, 10, mg, Pack: 30 |
Lek Pharmaceuticals d.d., Словения |
Lek Pharmaceutical d.d., Slovenia |
3.36 |
0.67 |
4.03 |
7% |
0.24 |
3.6 |
0.72 |
4.32 |
20% |
0.67 |
4.27 |
0.85 |
5.12 |
|
НСР-1526/25.10.2013 |
12.11.2013 |
12.11.2013 |
Неактивен |
3447 |
| Atorvastatin |
ІІ-14748/08.11.2006 г. |
TULIP, Film coated tablet, 20, mg, Pack: 30 |
Lek Pharmaceuticals d.d., Словения |
Lek Pharmaceutical d.d., Slovenia |
6.49 |
1.3 |
7.79 |
7% |
0.45 |
6.94 |
1.39 |
8.33 |
20% |
1.3 |
8.24 |
1.65 |
9.89 |
|
НСР-1527/25.10.2013 |
12.11.2013 |
12.11.2013 |
Неактивен |
3448 |
| Atorvastatin |
ІІ-14748/08.11.2006 г. |
TULIP, Film coated tablet, 20, mg, Pack: 30 |
Lek Pharmaceuticals d.d., Словения |
Lek Pharmaceutical d.d., Slovenia |
7.2 |
1.44 |
8.64 |
7% |
0.5 |
7.7 |
1.54 |
9.24 |
20% |
1.44 |
9.14 |
1.83 |
10.97 |
|
КЦРР-785/15.06.2012 |
03.07.2012 |
03.07.2012 |
Неактивен |
3448 |
| Atorvastatin |
ІІ-14747/08.11.2006 г. |
TULIP, Film coated tablet, 10, mg, Pack: 30 |
Lek Pharmaceuticals d.d., Словения |
Lek Pharmaceutical d.d., Slovenia |
4.13 |
0.83 |
4.96 |
7% |
0.29 |
4.42 |
0.88 |
5.3 |
20% |
0.83 |
5.25 |
1.05 |
6.3 |
|
КЦРР-785/15.06.2012 |
03.07.2012 |
03.07.2012 |
Неактивен |
3447 |
| Atorvastatin |
ІІ-14748/ 08.11.2006 г. |
TULIP, Film coated tablet, 20, mg, Pack: 30 |
Lek Pharmaceuticals d.d., Словения |
Lek Pharmaceuticals d.d., Slovenia |
9.13 |
1.83 |
10.96 |
9% |
0.82 |
9.95 |
1.99 |
11.94 |
22% |
2.01 |
11.96 |
2.39 |
14.35 |
|
КЦРР-653/19.05.2012 |
04.06.2012 |
04.06.2012 |
Неактивен |
3448 |
| Atorvastatin |
ІІ-14747/08.11.2006 г. |
TULIP, Film coated tablet, 10, mg, Pack: 30 |
Lek Pharmaceuticals d.d., Словения |
Lek Pharmaceuticals d.d., Slovenia |
5.71 |
1.14 |
6.85 |
9% |
0.51 |
6.22 |
1.24 |
7.46 |
22% |
1.26 |
7.48 |
1.5 |
8.98 |
|
КЦ-527/13.02.2009 |
02.03.2009 |
02.03.2009 |
Неактивен |
3447 |
| Atorvastatin |
ІІ-14748/08.11.2006 г. |
TULIP, Film coated tablet, 20, mg, Pack: 30 |
Lek Pharmaceuticals d.d., Словения |
Lek Pharmaceuticals d.d., Slovenia |
11.44 |
2.29 |
13.73 |
8% |
0.92 |
12.36 |
2.47 |
14.83 |
20% |
2.29 |
14.65 |
2.93 |
17.58 |
|
КЦ-527/13.02.2009 |
02.03.2009 |
02.03.2009 |
Неактивен |
3448 |
| Hepatitis A (inactivated), hepatitis B (rDNA) (HAB) vaccine (adsorbed) |
EU/1/96/020/007 |
TWINRIX ADULT, Suspension for injection, 1ml, ml (1 dose = 1 ml), Pack: 1 pre-filled syringe + 1 separate needle |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium |
38.98 |
7.8 |
46.78 |
4% |
1.56 |
40.54 |
8.11 |
48.65 |
16% |
6.24 |
46.78 |
9.36 |
56.14 |
|
НСР-7782/28.12.2015 |
13.01.2016 |
13.01.2016 |
Активен |
129 |
| Hepatitis A (inactivated), hepatitis B (rDNA) (HAB) vaccine (adsorbed) |
EU/1/96/020/007 |
TWINRIX ADULT, Suspension for injection, 1ml, -, Pack: 1 pre-filled syringe + 1 separate needle |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium |
38.98 |
7.8 |
46.78 |
4% |
1.56 |
40.54 |
8.11 |
48.65 |
16% |
6.24 |
46.78 |
9.36 |
56.14 |
|
НСР-7782/28.12.2015 |
13.01.2016 |
13.01.2016 |
Неактивен |
129 |
| Hepatitis A (inactivated), hepatitis B (rDNA) (HAB) vaccine (adsorbed) |
EU/1/96/020/007 |
TWINRIX ADULT, Suspension for injection, 1ml, -, Pack: 1 pre-filled syringe + 1 separate needle |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium |
38.98 |
7.8 |
46.78 |
4% |
1.56 |
40.54 |
8.11 |
48.65 |
16% |
6.24 |
46.78 |
9.36 |
56.14 |
|
НСР-7782/28.12.2015 |
13.01.2016 |
13.01.2016 |
Неактивен |
129 |
| Hepatitis A (inactivated), hepatitis B (rDNA) (HAB) vaccine (adsorbed) |
ЕU/1/96/020/001-009 |
TWINRIX ADULT, Suspension for injection, 20 mcg/1 ml, 1 dose=1 ml, Pack: 1 |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals S.A., Belgium |
40.33 |
8.07 |
48.4 |
4% |
1.61 |
41.94 |
8.39 |
50.33 |
16% |
6.45 |
48.39 |
9.68 |
58.07 |
цената се заличава КЦРР-1641/15.11.2012 |
КЦРР-743/07.06.2012 |
26.06.2012 |
26.06.2012 |
Заличен |
1244 |
| Hepatitis A (inactivated), hepatitis B (rDNA) (HAB) vaccine (adsorbed) |
ЕU/1/96/020/001-009 |
TWINRIX ADULT, Suspension for injection, 20 mcg/1 ml, 1 dose=1 ml, Pack: 1 |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals S.A., Belgium |
42.36 |
8.47 |
50.83 |
6% |
2.54 |
44.9 |
8.98 |
53.88 |
18% |
7.62 |
52.52 |
10.5 |
63.02 |
|
КЦ-1483/31.03.2010 |
21.04.2010 |
21.04.2010 |
Неактивен |
1244 |
| Hepatitis A (inactivated), hepatitis B (rDNA) (HAB) vaccine (adsorbed) |
EU/1/96/020/007 |
Twinrix Adult suspension injection vial 20 mcg 1 ml, Hepatitis A virus (inactivated) 720 ELSA Units, Hepatitis B surface antigen 20 mcg x 1 dose, Suspension for injection, Hepatitis A virus (inactivated) 720 ELISA Units / Hepatitis B surface antigen 20 μg, 1 dose=1 ml, Pack: 1 |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium |
42.36 |
8.47 |
50.83 |
4% |
1.69 |
44.05 |
8.81 |
52.86 |
16% |
6.78 |
50.83 |
10.17 |
61 |
|
КЦ-262/27.10.2008 |
18.11.2008 |
18.11.2008 |
Неактивен |
129 |
| Telmisartan, Amlodipine |
EU/1/10/648/016 |
TWYNSTA, Tablet, 80 mg/ 5, mg, Pack: 28 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Pharma GmbH & Co. KG, Germany |
29.81 |
5.96 |
35.77 |
6% |
1.79 |
31.6 |
6.32 |
37.92 |
18% |
5.37 |
36.97 |
7.39 |
44.36 |
|
НСР-7909/28.01.2016.; НСР-10439/29.09.2016 |
02.11.2016 |
02.11.2016 |
Активен |
3098 |